tyrosyl-isoleucyl-glycyl-seryl-arginine has been researched along with cyclin d1 in 1 studies
| Studies (tyrosyl-isoleucyl-glycyl-seryl-arginine) | Trials (tyrosyl-isoleucyl-glycyl-seryl-arginine) | Recent Studies (post-2010) (tyrosyl-isoleucyl-glycyl-seryl-arginine) | Studies (cyclin d1) | Trials (cyclin d1) | Recent Studies (post-2010) (cyclin d1) |
|---|---|---|---|---|---|
| 111 | 0 | 29 | 10,885 | 70 | 5,157 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Guo, L; Wang, W; Yu, Y; Yuan, Z; Zhou, R | 1 |
1 other study(ies) available for tyrosyl-isoleucyl-glycyl-seryl-arginine and cyclin d1
| Article | Year |
|---|---|
Peptide REDV-modified polysaccharide hydrogel with endothelial cell selectivity for the promotion of angiogenesis.
Topics: 3T3 Cells; Actin Cytoskeleton; Alginates; Animals; Blood Vessels; Cell Adhesion; Cell Movement; Cell Proliferation; Cyclin D1; Female; Glucuronic Acid; Hexuronic Acids; Human Umbilical Vein Endothelial Cells; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Mice; Neovascularization, Physiologic; Oligopeptides; Peptides; Rats, Wistar; Spectroscopy, Fourier Transform Infrared; Tissue Scaffolds | 2015 |